Showing results (101-110 of 176) with videos related to
Sort By:
Pageof 18
Diagnostics (Basel, Switzerland)|April 9, 2020
Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian CarcinomaKohei Nakamura, Eriko Aimono, Shigeki Tanishima, et al.Frontiers in Human Neuroscience|August 12, 2021
The Menstrual Cycle Alters Resting-State Cortical Activity: A Magnetoencephalography StudyRika Haraguchi, Hideyuki Hoshi, Sayuri Ichikawa, et al.Thoracic Cancer|October 21, 2025
Acquired MTAP Loss Following Entrectinib Resistance in ROS1-Rearranged NSCLC With CD74 Exon 3-ROS1 Exon 34 FusionMizuha Haraguchi Hashiguchi, Maika Tanino, Suzuyuki Yoneda, et al.Experimental and Therapeutic Medicine|August 15, 2019
Clinicopathological and biological analysis of PIK3CA mutation and amplification in cervical carcinomasSultana Razia, Kentaro Nakayama, Kohei Nakamura, et al.Oncology Letters|November 30, 2016
Letrozole as second-line hormonal treatment for recurrent low-grade endometrial stromal sarcoma: A case report and review of the literatureKohei Nakamura, Kentaro Nakayama, Masako Ishikawa, et al.The Keio Journal of Medicine|March 12, 2025
Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HBOC)Kohei Nakamura, Kenta Masuda, Tomoko Seki, et al.Healthcare (Basel, Switzerland)|April 23, 2022
Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer AgentsYuki Nonomura, Kentaro Nakayama, Kohei Nakamura, et al.Future Oncology (London, England)|July 12, 2022
Real-world application of next-generation sequencing-based test for surgically resectable colorectal cancer in clinical practiceMasayo Ogiri, Ryo Seishima, Kohei Nakamura, et al.European Journal of Radiology|December 23, 2025
Elevated 18F-FDG uptake in non-metastatic lymph nodes of POLE-mutated endometrial cancer on PET/CTMaho Kurihara, Yu Iwabuchi, Yoshitake Yamada, et al.BJC Reports|May 20, 2025
Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classificationTakuma Yoshimura, Kohei Nakamura, Tatsuyuki Chiyoda, et al.Pageof 18